George Todorov

Cell and Ex Vivo Gene Therapies: A Manufacturing Odyssey

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task? Technology companies are on the case and new solutions are emerging. Here, we explore the key considerations when developing ex vivo gene therapy and cell therapy processes for commercial manufacturing.